stoxline Quote Chart Rank Option Currency Glossary
  
Catheter Precision, Inc. (VTAK)
0.6001  0.054 (9.83%)    06-12 15:56
Open: 0.55
High: 0.6188
Volume: 1,341,161
  
Pre. Close: 0.5464
Low: 0.55
Market Cap: 5(M)
Technical analysis
2024-06-12 4:25:55 PM
Short term     
Mid term     
Targets 6-month :  0.75 1-year :  0.88
Resists First :  0.64 Second :  0.75
Pivot price 0.52
Supports First :  0.54 Second :  0.47
MAs MA(5) :  0.54 MA(20) :  0.54
MA(100) :  0.5 MA(250) :  0.53
MACD MACD :  0 Signal :  -0.1
%K %D K(14,3) :  57 D(3) :  42.7
RSI RSI(14): 61.5
52-week High :  1.13 Low :  0.34
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.
[ VTAK ] has closed Bollinger Bands are 33.9% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 0.62 - 0.62 0.62 - 0.62
Low: 0.54 - 0.55 0.55 - 0.55
Close: 0.6 - 0.6 0.6 - 0.6
Company Description

Catheter Precision, Inc. develops and delivers electrophysiology products to provide patients, hospitals, and physicians with technologies and solutions to improve the lives of patients with cardiac arrhythmias in the United States. The company's lead product is View into Ventricular Onset System, a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. It also provides LockeT, a suture retention device; and Amigo Remote Catheter System, a robotic arm that serves as a catheter control device. The company was formerly known as Ra Medical Systems, Inc and changed its name to Catheter Precision, Inc. in August 2023. Catheter Precision, Inc. is based in Fort Mill, South Carolina.

Headline News

Fri, 24 May 2024
"Cutting-Edge Medical Innovations Propel Catheter Precision - openPR

Thu, 02 May 2024
Uncovering the Deep Value in Catheter Precision (NYSE: VTAK) - Insider Financial

Wed, 24 Apr 2024
Catheter Precision, Inc. (VTAK) Announces Receipt of First Purchase Order for LockeT from HCA Healthcare Facility - Sacramento Bee

Thu, 25 Jan 2024
Catheter Precision, Inc. (VTAK) Secures New Distributor for VIVO in Turkey - Kansas City Star

Tue, 23 Jan 2024
Catheter Precision And 2 Other Stocks Under $2 Insiders Are Buying - Allied Gaming (NASDAQ:AGAE), Vivani - Benzinga

Mon, 22 Jan 2024
Catheter Precision, Inc. (VTAK) Secures New Distributor in Brazil for LockeT - Raleigh News & Observer

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Underperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Outperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Neutral
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Underperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Underperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Underperform
Stock Basics & Statistics
Exchange:
AMEX
Sector:
Healthcare
Industry:
Medical - Devices
Shares Out 0 (M)
Shares Float 6 (M)
Held by Insiders 4.6e+006 (%)
Held by Institutions 33.3 (%)
Shares Short 58 (K)
Shares Short P.Month 0 (K)
Stock Financials
EPS -2.62e+007
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0
Profit Margin 0 %
Operating Margin -12 %
Return on Assets (ttm) 232.9 %
Return on Equity (ttm) -47.9 %
Qtrly Rev. Growth 90000 %
Gross Profit (p.s.) 0
Sales Per Share 0
EBITDA (p.s.) 0
Qtrly Earnings Growth -37 %
Operating Cash Flow 0 (M)
Levered Free Cash Flow -26 (M)
Stock Valuations
PE Ratio -0.01
PEG Ratio 0
Price to Book value 0
Price to Sales 0
Price to Cash Flow 0
Stock Dividends
Dividend 0
Forward Dividend 27860
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android